Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000912057-02-014555
Filing Date
2002-04-11
Accepted
2002-04-11 00:00:00
Documents
7
Period of Report
2001-12-31

Document Format Files

Seq Description Document Type Size
1 10-K a2075146z10-k.htm 10-K 445265
3 EX-10.01 a2075146zex-10_01.txt EX-10.01 23949
4 EX-10.02 a2075146zex-10_02.txt EX-10.02 35288
5 EX-10.03 a2075146zex-10_03.txt EX-10.03 38096
6 EX-10-04 a2075146zex-10_04.txt EX-10.04 16668
7 EXHIBIT 10.05 a2075146zex-10_05.txt EX-10.05 20250
8 EXHIBIT 99.01 a2075146zex-99_01.txt EX-99.01 1304
  Complete submission text file 0000912057-02-014555.txt   583049
Mailing Address C/O WILSON SONSIN GOODRICH & ROSETI 650 PAGE MILL ROAD PALO ALTO CA 94304
Business Address 100 CORPORATE NORTH STE 215 BANNOCKBURN IL 60015 8472958678
NEOPHARM INC (Filer) CIK: 0000942788 (see all company filings)

EIN.: 510327886 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-12493 | Film No.: 02607722
SIC: 2836 Biological Products, (No Diagnostic Substances)